A Study of GC203 TIL in Advanced Malignant Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Solid Tumor · Gynecologic Cancer · Breast Cancer · Gastrointestinal Cancer · Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Xiaohua Wu, PhD) · Wu.xh@fudan.edu.cn · +862164175590

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Refractory Cancer · Recurrent Cancer · Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Stanford, United States · Aurora, United States

Propofol vs Sevo for Paediatric Tumor Surgery

Solid Tumor · Carcinoma · Malignancy

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Cancer · Solid Malignant Tumors · SCC - Squamous Cell Carcinoma

Abroad (travel likely)Recruiting

Nashville, United States

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Acute Kidney Injury · Chronic Kidney Diseases · Solid-organ Transplantation

Abroad (travel likely)Recruiting

Toulouse, France